Malaria drug tested for deadly lung condition
NCT ID NCT06872112
Summary
This early-stage study is testing whether a daily pill of artesunate, a drug used for malaria, is safe for people with pulmonary arterial hypertension (PAH). It will involve about 15 adults with PAH who are already on standard treatments. The main goal is to find a safe dose by slowly increasing the amount given and watching for side effects over 20 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.